$1.83
Market Cap
$266.71M
Shares Outstanding
141.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 18, 2014
Round Lot
100
Locale
US
Day Open
$1.89
Day High
$1.89
Day Low
$1.83
Volume
569.3K
VWAP
$1.86
Prev Close
$1.89
Transactions
--
Acc. Volume
--
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
ProQR Therapeutics N.V. Ordinary Shares (PRQR) closed the 2026-09-18 session at $1.83, down 3.17% versus the previous close (-0.06). The stock opened at $1.89 and traded between $1.83 and $1.89 during that session. Session trading volume was 569K shares. The volume-weighted average price (VWAP) is $1.86.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
ProQR Therapeutics N.V. Ordinary Shares has a market capitalization of $266.7 million. PRQR is listed on the XNAS exchange. The company employs approximately 187 people. The recorded listing date is 2014-09-18.
On this page you can find market PRQR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.